4,599 Shares in Solventum Co. (NYSE:SOLV) Bought by Centaurus Financial Inc.

Centaurus Financial Inc. acquired a new position in shares of Solventum Co. (NYSE:SOLV) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,599 shares of the company’s stock, valued at approximately $321,000.

A number of other large investors have also recently bought and sold shares of SOLV. Copeland Capital Management LLC bought a new position in shares of Solventum in the 3rd quarter valued at $26,000. Mather Group LLC. bought a new position in Solventum in the third quarter valued at about $27,000. EverSource Wealth Advisors LLC acquired a new position in Solventum during the first quarter worth about $30,000. Hollencrest Capital Management bought a new position in shares of Solventum in the second quarter worth about $25,000. Finally, Deseret Mutual Benefit Administrators acquired a new stake in shares of Solventum in the 2nd quarter valued at approximately $25,000.

Analysts Set New Price Targets

SOLV has been the subject of several research reports. BTIG Research assumed coverage on shares of Solventum in a research note on Thursday, September 5th. They issued a “neutral” rating for the company. Morgan Stanley increased their price target on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Stifel Nicolaus began coverage on Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price for the company. Finally, Wells Fargo & Company cut their price target on Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Friday, August 9th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $68.00.

Solventum Trading Down 0.2 %

NYSE SOLV opened at $71.50 on Wednesday. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The business’s 50-day moving average price is $70.51 and its two-hundred day moving average price is $62.40.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.